Williamson E A, Burgess G S, Eder P, Litz-Jackson S, Boswell H S
Walther Oncology Center, Indiana University School of Medicine, Indianapolis, USA.
Leukemia. 1997 Jan;11(1):73-85. doi: 10.1038/sj.leu.2400551.
Raised intracellular cyclic AMP (cAMP) has been demonstrated to exert an antiproliferative effect in myeloid cells. How the antiproliferative activity of cAMP is exerted in p210 BCR-ABL transformed myeloid cells was the subject of this investigation. It was hypothesized that cyclin dependent kinase 4, cdk4, might be a critical target enzyme to affect the related events of c-myc transcription and progression through G1 phase of the cell cycle within cells transformed by p210 BCR-ABL, and further, that cdk4 might be downregulated by cAMP to inhibit proliferation. In order to investigate the regulatory role of cdk4, synchronized cells were studied. In p210 BCR-ABL transformed cells transiting early G1 phase, treatment with a cAMP analogue led to inhibition of cyclin D1 synthesis, and marked reduction of cdk4 kinase activity. Within cells in which cdk4 was inhibited by cAMP, there was augmented interaction of E2F1 with the retinoblastoma protein, pRb in a nuclear matrix-associated cell fraction. As a result of E2F1 sequestration, raised intracellular cAMP was found to inhibit c-myc transcription in p210 BCR-ABL transformed myeloid cells synchronously transiting the early G1 phase of the cell cycle. A target of this transcriptional suppression exerted by cAMP was the E2F site of the c-myc P2 promoter. On the other hand, cyclin D1 content was not reduced by cAMP in these cells when it was applied at a later cell cycle stage at the interface between G1 and S. Corresponding to lack of cyclin D1 inhibition in these later G1-to-S phase cells, cdk4 activity was only modestly suppressed, and c-myc mRNA expression was also inhibited to a lesser degree. These studies show that Rb interaction with E2F1 is regulated by cdk4 and cyclin D1 within p210 BCR-ABL transformed leukemia cells in early G1 phase of the cell cycle. In this context, both cyclin D1 and cdk4 are subject to the level of intracellular cAMP. This interaction between Rb and E2F1, which is subject to the level of cAMP, is critical to transcriptional control of c-myc. Further, pRb regulation of E2F activity affects cellular potential for G1-S phase transition in p210 BCR-ABL transformed myeloid cells, in part, via its effect on c-myc transcription.
细胞内环状AMP(cAMP)水平升高已被证明在髓系细胞中具有抗增殖作用。本研究的主题是cAMP的抗增殖活性如何在p210 BCR-ABL转化的髓系细胞中发挥作用。研究假设,细胞周期蛋白依赖性激酶4(cdk4)可能是影响p210 BCR-ABL转化细胞中c-myc转录相关事件及细胞通过G1期进程的关键靶酶,此外,cAMP可能通过下调cdk4来抑制细胞增殖。为了研究cdk4的调节作用,对同步化细胞进行了研究。在处于早期G1期的p210 BCR-ABL转化细胞中,用cAMP类似物处理导致细胞周期蛋白D1合成受到抑制,cdk4激酶活性显著降低。在cdk4被cAMP抑制的细胞内,在核基质相关细胞组分中,E2F1与视网膜母细胞瘤蛋白(pRb)的相互作用增强。由于E2F1被隔离,发现细胞内cAMP水平升高会抑制处于细胞周期早期G1期的p210 BCR-ABL转化髓系细胞中的c-myc转录。cAMP施加的这种转录抑制作用的一个靶点是c-myc P2启动子的E2F位点。另一方面,当在细胞周期后期G1与S期交界处应用cAMP时,这些细胞中的细胞周期蛋白D1含量并未降低。与这些G1至S期后期细胞中细胞周期蛋白D1未受抑制相对应,cdk4活性仅受到适度抑制,c-myc mRNA表达也受到较小程度的抑制。这些研究表明,在细胞周期早期G1期的p210 BCR-ABL转化白血病细胞中,Rb与E2F1的相互作用受cdk4和细胞周期蛋白D1调节。在这种情况下,细胞周期蛋白D1和cdk4均受细胞内cAMP水平影响。Rb与E2F1之间这种受cAMP水平影响的相互作用,对于c-myc的转录控制至关重要。此外,pRb对E2F活性的调节部分通过其对c-myc转录的影响,进而影响p210 BCR-ABL转化髓系细胞从G1期向S期转变的细胞潜能。